Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
about
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsAcetylation Reader Proteins: Linking Acetylation Signaling to Genome Maintenance and CancerMolecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report.Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaThe heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors.Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells.A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin.
P2860
Q27027491-4A83A661-07C0-4594-A788-8A646491A661Q28076086-67C9EB92-3C53-4F1F-AC17-D12AEABD7EB4Q37222794-C83F645D-98D1-45CB-85A5-D39D9A8561B6Q37330090-D49B8ADC-803B-4457-914C-8D3066965FCEQ38673964-E2647E95-54CD-4266-A58A-9634F233CE65Q38752460-877AC1E4-7C8D-449E-9AD3-2DE8A7114924Q38843100-016BEDCD-B7C5-4637-AB35-B7F1208F710CQ38848546-11EB641A-11AC-4832-96ED-A7E6885FDAD8Q39287526-8C3A85CB-31B8-4409-9B0F-1563F2F9AC3DQ47393027-F38C58B3-5CF2-4AF9-A716-40B07B92823AQ47637390-973404FA-AEDA-4154-B085-F3512E01DBEA
P2860
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@ast
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@en
type
label
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@ast
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@en
prefLabel
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@ast
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@en
P2093
P2860
P1433
P1476
Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
@en
P2093
Jen-Der Lin
Richard J Wong
Ting-Chao Chou
P2860
P304
P356
10.1371/JOURNAL.PONE.0077684
P407
P577
2013-10-14T00:00:00Z